Clinlogix, a clinical research organization located just outside Philadelphia, is proud to announce its selection by the UPstart program at the University of Pennsylvania as a preferred Clinical Research Organization. The UPstart program strives to maximize the potential of University of Pennsylvania research and technologies through the creation and stimulus of entrepreneurial endeavors. Clinlogix is extremely excited about this partnership, which allows the company to leverage its extensive clinical and regulatory experience and transfer that knowledge to a variety of UPSTART projects.
Michael Poisel, UPstart Director, stated that “So much of the success of our UPstart companies is determined by the involvement of our many partners along the way. We are excited to have the Clinlogix team join us and add their significant experience in the development of these exciting young businesses.”
JeanMarie Markham, President and CEO of Clinlogix, stated that “The relevance of this relationship is the recognition that early stage, academic research is beginning to think beyond its borders. Historically there have been challenges in the process of ‘translating’ academic research and concepts into a ‘commercial’ product and viable company. The selection of Clinlogix by UPstart reflects the organization’s forward thinking. UPstart is beginning with the end in mind. With limited financial resources, the goal is to make the most impact by developing viable strategic development plans. “
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.